glp-1 type 2 diabetes List of approved and pending medications GLP-1 Receptor Agonists | Incretin

They advise patients experiencing sudden vision loss or rapidly worsening eyesight to seek medical attention immediately

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Understanding GLP-1, Metabolism, Weight Loss and the Side Effects of Ozempic Before you consider weight-loss injections, there is something im...

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Combining GLP-1 treatments with biologics